Wittenberg Investment Management’s Lifecore Biomedical LFCR Stock Holding History

Wittenberg Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	301,815 +280,092	+1,289%	+$1.93M	0.42%	39
2025 Q4	$178K	Buy	21,723 +4,500	+26%	+$33.3K	0.07%	70
2025 Q3	$127K	Hold	17,223	–	–	0.05%	74
2025 Q2	$140K	Buy	17,223 +5,000	+41%	+$33.7K	0.06%	73
2025 Q1	$86K	Buy	12,223 +1,000	+9%	+$6.21K	0.04%	73
2024 Q4	$83.4K	Sell	11,223 -46,673	-81%	-$298K	0.03%	73
2024 Q3	$285K	Buy	57,896 +42,967	+288%	+$224K	0.09%	71
2024 Q2	$76.6K	Buy	+14,929	New	+$88.4K	0.03%	81

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return